United States · Biometrics startup
United States · teiko.bio
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
Funding reportedLast round: Seed
What company datasets say teiko.bio raised
Funding, as reported
Reported in all$12Min dollars
Rounds3
Last roundSeed
Last round dateMar 2022
Investors listed11
SEC Form D$12M sold, 1 filing, last Oct 2021
Founders and team
From teiko.bio's own website and the SEC filings it signed: 5 on the team.
- Ramji SrinivasanCofounder and CEO
- Arya IyerResearch Associate
- Hannah SelkenBusiness Development Manager
- Jillian HarringtonCLIA Lab Director
- Sacha MartinyAssociate Scientist
On the board, as filediMatthew SpitzerVictor Wang
On 6 portfolio pages
Investors who name them
Each firm lists teiko.bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biometrics in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put teiko.bio in front of investors. Or tell us what we have wrong.